SCHEMBL1630445

SCHEMBL1630445

O=C(Nc1cccc(-n2nccc2-c2ccc(O)cc2O)c1)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.48
KCNK3 O14649 6/20 0.47
KCNK9 Q9NPC2 4/20 0.47
TYR P14679 1/20 0.47
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
BRAF P15056 1/20 0.44
SIRT1 Q96EB6 1/20 0.43
PDGFRB P09619 1/20 0.43
KDR P35968 1/20 0.43
PTGER1 P34995 1/20 0.43
HPGD P15428 1/20 0.42
ALDH1A1 P00352 1/20 0.42
MAPT P10636 1/20 0.42
LPAR3 Q9UBY5 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1628592 0.93 KCNK3 (0.49) POLBKCNK3KCNK9NPC1RAB9A
SCHEMBL1631560 0.90 KCNK3 (0.52) KCNK3NPC1RAB9AKMT2AMEN1
SCHEMBL1629510 0.89 TYR (0.48) POLBTYRNPC1RAB9AKMT2A
SCHEMBL1628948 0.87 GRM4 (0.49) KCNK3KCNK9NPC1RAB9AKMT2A
SCHEMBL12722777 0.85 ALDH1A1 (0.55) POLBKMT2AMEN1PTGER1HPGD
SCHEMBL1630489 0.83 PTGER1 (0.55) POLBKMT2AMEN1PTGER1HPGD
SCHEMBL1629175 0.80 TYR (0.48) POLBTYRHPGDALDH1A1MAPT
SCHEMBL1629986 0.80 GAA (0.50) POLBRAB9AKMT2AMEN1MAPT
SCHEMBL1630409 0.79 HSP90AA1 (0.51) POLBKMT2AMEN1PTGER1ALDH1A1
SCHEMBL1630376 0.79 RAB9A (0.54) NPC1RAB9AKMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP disclosed
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 US disclosed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085904-A1 1,5-Diphenylpyrazoles HSP90AB1, HSP90AA1, HSP90AB2P POLB 3527/4885KCNK3 2881/4885KCNK9 4176/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.